CIK 0001665988
- Accelerated filer
- Emerging growth company
Bioventus Inc.
Sign in to watch- Ticker
- BVS
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 810980861
- Phone
- +1 919-474-6700
- Business address
- 4721 EMPEROR BOULEVARD, SUITE 100, DURHAM, NC, 27703
- 4 Open-market sale Chief Executive Officer sold 9,811 shares at $1.39 ($13,625)
- 4 Open-market sale SVP & Chief Compliance Officer sold 1,332 shares at $1.39 ($1,850)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Exercise or conversion Director acquired 965 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Exercise or conversion Director acquired 965 shares (option exercise)
- 4 Exercise or conversion Director acquired 385 shares (option exercise)
- 4 Exercise or conversion Director acquired 1,813 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 2,780,923 shares (grant or award)
- 4 Exercise or conversion Director acquired 40,573 shares (option exercise)
- 4 Open-market sale SVP & General Counsel sold 16,016 shares at $11.19 ($179,238)
- 4 Open-market sale Chief Commercial Officer sold 65,963 shares at $11.12 ($733,502)
- 4 Exercise or conversion Director acquired 2,700 shares (option exercise)
- 4 Exercise or conversion Director acquired 2,700 shares (option exercise)
- 4 Exercise or conversion Director acquired 2,700 shares (option exercise)
Page 9 of 13 · 251 filings